|
Biliary Atresia Research Consortium Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or professional assistance by using a genuine doctor. We aren't mDs. Always consult your physician about Biliary Atresia Research Consortium conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Biliary Atresia Research Consortium Clinical research trials and Biliary Atresia Research Consortium health trials occur in a lot of of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new does drugs. The role of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Biliary Atresia Research Consortium. Biliary Atresia Research Consortium Clinical Trials and other clinical trials permit volunteers to get medical treatment choices before they are available to the general public. Many times the test subjects get professional assistance for free of charge, and occasionally they are compensated for their time. Sometimes there is a cost for a Biliary Atresia Research Consortium clinical trial. Human subjects often get the best healthcare possible for their Biliary Atresia Research Consortium condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, medical hazards (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "B" Clinical Trials Conditions > Biliary Atresia Research Consortium Biliary Atresia Research Consortium
Biliary Atresia Research Consortium
For Condition: Cholestasis,Biliary Atresia
Status: Not yet recruiting
Sponsor(s): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ,
Synopsis: Biliary atresia and idiopathic neonatal hepatitis are the most common causes of jaundice and hyperbilirubinemia that continue beyond the newborn period. The long term goal of the Biliary Atresia Research Consortium (BARC) is to establish a database of clinical information and serum and tissue samples from children with biliary atresia (BA) and idiopathic neonatal hepatitis (INH) to facilitate research and to perform clinical, epidemiological and therapeutic trials in these two important pediatric liver diseases.
Details:
Eligibility:
Study Type: Observational, Natural History, Longitudinal, Defined Population, Retrospective/Prospective Study
Minimum Age/Maximum Age: /6 Months
Genders: Both
Protocol Entry Criteria: Age less or equal to 180 days at presentation to clinical site. Clinically meaningful cholestasis due to primary hepatobiliary disease.
Total Enrollment: 400
Location and Contact Information:
Overall Study Official:
RonaldSokol, Study Chair, The Children's Hospital, Denver
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15213
United States
David Perlmutter 412-692-8071
The Children's Hospital
Denver, Colorado, 80218
United States
Ronald Sokol 303-861-6669
Children's Memorial Hospital
Chicago, Illinois, 60614
United States
Peter Whitington 773-880-4643
Johns Hopkins School of Medicine
Baltimore, Maryland, 21287
United States
Kathleen Schwarz 410-955-8769
Mount Sinai Medical Center
New York City, New York, 10029
United States
Benjamin Shneider 212-241-6227
Children's Hospital Medical Center
Cincinnati, Ohio, 45229
United States
Jorge Bezerra 513-636-4928
Washington University School of Medicine
St. Louis, Missouri, 63110
United States
Ross Shepherd 314-454-2337
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104
United States
Barbara Haber 215-590-3606
University of California
San Francisco, California, 94143
United States
Philip Rosenthal 415-476-5892
Additional Information:
Study ID Numbers: BARC; U01-DK62456-01
Study Start Date:
Record last reviewed: December 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00061828
Other Biliary Atresia Studies:
1. Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease
2. Biliary Atresia Research Consortium
Related Studies:
Other Biliary Atresia Clinical Trials
Other Colorado Clinical Trials
Other Denver Clinical Trials
Biliary Atresia Research Consortium
|
|
|
|
|
|
|
|